₹22,688.00
-187.70 (-0.82%)
As of 21 Sept 2026, Neuland Laboratories Ltd share price is ₹22,688.00. The stock opened at ₹22,688.00 and had closed at ₹22,875.70 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹11,500.00 and a high of ₹24,235.05. In terms of performance, Neuland Laboratories Ltd share price has increased by 90.56% over the past six months and has increased by 49.48% over the last year.
NEULANDLAB Stock Price Chart
Neuland Laboratories Ltd Overview
Market cap₹29,349 Crs
Volume1,640
Prev. Close₹22,875.70
Year range₹11,500.00 - ₹24,235.05
ISININE794A01010
About NEULANDLAB
Neuland Laboratories engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.
Neuland Laboratories Ltd Historical Performance
1 Month Return-1.90%
6 Month Return84.37%
3 Year Return526.41%
3 Month Return32.91%
1 Year Return43.94%
5 Year Return1352.38%
Neuland Laboratories Ltd Fundamentals
ROCE(TTM)23.61%
P/E Ratio (TTM)59.08
P/B Ratio15.74
Debt to Equity0.16
ROE19.46%
EPS (TTM)387.19
Dividend Yield0.15%
Book Value1453.59
Profit Margin20.94%
Operating Margin27.97%
Neuland Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,053.15 | 1,497.35 | 1,571.12 | 1,200.95 | 953.16 |
| EBITDA | 603.41 | 419.21 | 474.47 | 281.06 | 144.27 |
| Net Profit | 363.11 | 259.43 | 299.60 | 163.12 | 63.53 |
| EPS | 283.01 | 202.20 | 233.51 | 127.14 | 49.74 |
Neuland Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 22,544.02 |
| Resistance 1 (R1) | 23,107.67 |
| Pivot Point | 22,775.98 |
Neuland Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 24-Jul-2026 | 12-May-2026 | 24-Jul-2026 | Final | ₹34.00 |
| 18-Jul-2025 | 15-May-2025 | 18-Jul-2025 | Final | ₹12.00 |
| 12-Jul-2024 | 10-May-2024 | 13-Jul-2024 | Final | ₹14.00 |
| 11-Jul-2023 | 11-May-2023 | 12-Jul-2023 | Final | ₹10.00 |
| 14-Jul-2022 | 10-May-2022 | 15-Jul-2022 | Final | ₹5.00 |
NEULANDLAB Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| D R Rao | Chairman |
| D Sucheth Rao | Vice Chairman / Executive Directorector / WTD |
| D Saharsh Rao | Managing Director & Chief Executive Officer |
Neuland Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Neuland Laboratories Ltd today is ₹22,688.00 on NSE and ₹22,688.00 on BSE.
- The 52-week high of Neuland Laboratories Ltd is ₹24,235.05, while the 52-week low is ₹11,500.00.
- The current market capitalisation of Neuland Laboratories Ltd is approximately ₹29,349 crore.
- The P/E (Price-to-Earnings) ratio of Neuland Laboratories Ltd is 91.51. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Neuland Laboratories Ltd is 10.12. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Neuland Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for NEULANDLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Neuland Laboratories Ltd has delivered a return of approximately 526.41%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Neuland Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 32.62% promoters, 8.42% FIIs, 16.51% DIIs, and 22.88% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
